Abstract
Current Epilepsy therapies are inadequate as at least 30% of all patients develop pharmacoresistance and/or suffer from psychiatric comorbidities as well as significant side-effects from antiepileptic drugs. Anterior nucleus of the thalamus deep brain stimulation (ANT-DBS) was recently approved in the US and Brazil, as an alternative treatment option for patients with medically refractory…